Medicines and vaccines supply chains challenges in Nigeria: a scoping review

Background: Medicines and vaccines supply chains represent critical systems for realising one of the major targets of the United Nations’ third Sustainable Development Goals (SDGs)—access to safe, effective, quality, and affordable essential medicines and vaccines, for all. However, evidence suggest...

Full description

Bibliographic Details
Main Authors: Olutuase, V.O., Iwu-Jaja, C.J., Akuoko, C.P., Adewuyi, Emmanuel, Khanal, V.
Format: Journal Article
Language:English
Published: 2022
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/97668
_version_ 1848766300743008256
author Olutuase, V.O.
Iwu-Jaja, C.J.
Akuoko, C.P.
Adewuyi, Emmanuel
Khanal, V.
author_facet Olutuase, V.O.
Iwu-Jaja, C.J.
Akuoko, C.P.
Adewuyi, Emmanuel
Khanal, V.
author_sort Olutuase, V.O.
building Curtin Institutional Repository
collection Online Access
description Background: Medicines and vaccines supply chains represent critical systems for realising one of the major targets of the United Nations’ third Sustainable Development Goals (SDGs)—access to safe, effective, quality, and affordable essential medicines and vaccines, for all. However, evidence suggests the system is confronted with several challenges in many low-medium income countries, including Nigeria. This scoping review aims to summarize the available evidence on the challenges of medicines and vaccines supply chain system in Nigeria. Results: We searched relevant databases including Scopus and Web of Science for studies published between January 2005 and August 2020 on the challenges associated with medicines and vaccines supply chain systems in Nigeria. Our findings implicate several factors including difficulty with medicines or vaccines selection, procurement, distribution, and inventory management. Others included poor storage infrastructure, financial constraints, insecurity, transportation challenges, inadequate human resources, weak, or poorly implemented policies. These challenges mostly resulted in stock-outs of essential medicines which notably got worsened during the current COVID-19 pandemic. Conclusion: Our study is a wake-up call on the need to prioritise the critical sector of the supply chain systems for medicines and vaccines in Nigeria. Effective implementation of existing policies, improved security, strengthening of the health system through adequate budgetary allocations, and provision of infrastructure including regular availability of electricity are keys to surmounting the challenges and improving access to medicines or vaccines in Nigeria.
first_indexed 2025-11-14T11:48:58Z
format Journal Article
id curtin-20.500.11937-97668
institution Curtin University Malaysia
institution_category Local University
language eng
last_indexed 2025-11-14T11:48:58Z
publishDate 2022
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-976682025-05-03T08:15:24Z Medicines and vaccines supply chains challenges in Nigeria: a scoping review Olutuase, V.O. Iwu-Jaja, C.J. Akuoko, C.P. Adewuyi, Emmanuel Khanal, V. COVID-19 Humans Nigeria Pandemics SARS-CoV-2 Vaccines Humans Vaccines Nigeria Pandemics COVID-19 SARS-CoV-2 Background: Medicines and vaccines supply chains represent critical systems for realising one of the major targets of the United Nations’ third Sustainable Development Goals (SDGs)—access to safe, effective, quality, and affordable essential medicines and vaccines, for all. However, evidence suggests the system is confronted with several challenges in many low-medium income countries, including Nigeria. This scoping review aims to summarize the available evidence on the challenges of medicines and vaccines supply chain system in Nigeria. Results: We searched relevant databases including Scopus and Web of Science for studies published between January 2005 and August 2020 on the challenges associated with medicines and vaccines supply chain systems in Nigeria. Our findings implicate several factors including difficulty with medicines or vaccines selection, procurement, distribution, and inventory management. Others included poor storage infrastructure, financial constraints, insecurity, transportation challenges, inadequate human resources, weak, or poorly implemented policies. These challenges mostly resulted in stock-outs of essential medicines which notably got worsened during the current COVID-19 pandemic. Conclusion: Our study is a wake-up call on the need to prioritise the critical sector of the supply chain systems for medicines and vaccines in Nigeria. Effective implementation of existing policies, improved security, strengthening of the health system through adequate budgetary allocations, and provision of infrastructure including regular availability of electricity are keys to surmounting the challenges and improving access to medicines or vaccines in Nigeria. 2022 Journal Article http://hdl.handle.net/20.500.11937/97668 10.1186/s12889-021-12361-9 eng unknown
spellingShingle COVID-19
Humans
Nigeria
Pandemics
SARS-CoV-2
Vaccines
Humans
Vaccines
Nigeria
Pandemics
COVID-19
SARS-CoV-2
Olutuase, V.O.
Iwu-Jaja, C.J.
Akuoko, C.P.
Adewuyi, Emmanuel
Khanal, V.
Medicines and vaccines supply chains challenges in Nigeria: a scoping review
title Medicines and vaccines supply chains challenges in Nigeria: a scoping review
title_full Medicines and vaccines supply chains challenges in Nigeria: a scoping review
title_fullStr Medicines and vaccines supply chains challenges in Nigeria: a scoping review
title_full_unstemmed Medicines and vaccines supply chains challenges in Nigeria: a scoping review
title_short Medicines and vaccines supply chains challenges in Nigeria: a scoping review
title_sort medicines and vaccines supply chains challenges in nigeria: a scoping review
topic COVID-19
Humans
Nigeria
Pandemics
SARS-CoV-2
Vaccines
Humans
Vaccines
Nigeria
Pandemics
COVID-19
SARS-CoV-2
url http://hdl.handle.net/20.500.11937/97668